Loading...

hVIVO plc

HVO.L•LSE
Healthcare
Biotechnology
£10.00
£0.00(0.00%)

hVIVO plc (HVO.L) Stock Overview

Explore hVIVO plc’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B+

Score: 71.9/100

Key Financials

Market Cap68.7M
P/E Ratio3.97
EPS (TTM)$0.02
ROE0.42%
Fundamental Analysis

AI Price Forecasts

1 Week$9.77
1 Month$9.78
3 Months$13.33
1 Year Target$26.87

HVO.L Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of hVIVO plc (HVO.L) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 40.86, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $26.87.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 3.97 and a market capitalization of 68.7M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Frequently Asked Questions

;